hospital-acquired bacterial pneumonia

Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro
Fierce Pharma
Wed, 05/24/23 - 11:25 am
Innoviva
FDA
Entasis Therapeutics
Xacduro
ventilator-associated bacterial pneumonia
hospital-acquired bacterial pneumonia
Merck secures FDA approval for Recarbrio to treat adults with HABP/VABP
Pharmaceutical Business Review
Mon, 06/8/20 - 10:27 am
Merck
Recarbrio
hospital-acquired bacterial pneumonia
ventilator-associated bacterial pneumonia
FDA
Merck’s Recarbrio Shows Success in Late-Stage Trial for HABP/VABP Patients
BioSpace
Tue, 10/1/19 - 12:10 am
Merck
Recarbio
HABP/VABP
hospital-acquired bacterial pneumonia
Theravance Biopharma and Cumberland Pharmaceuticals Enter into $25 Million Antibiotic Deal
Xtalks
Wed, 11/7/18 - 11:57 am
Cumberland Pharmaceuticals
Theravance
antibiotic
Vibativ
hospital-acquired bacterial pneumonia
Merck to file for new use for antibiotic Zerbaxa
Pharmaforum
Tue, 09/11/18 - 11:47 am
Merck
Zerbaxa
hospital-acquired bacterial pneumonia
Theravance reintroduces Vibativ to the U.S. market
The Fly on the Wall
Wed, 08/14/13 - 11:21 am
Vibativ
Theravance
hospital-acquired bacterial pneumonia
Theravance Announces FDA Approval of VIBATIV(R) (telavancin) for the Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Yahoo/Market Wired
Sat, 06/22/13 - 10:25 am
Theravance
Vibativ
hospital-acquired bacterial pneumonia
pneumonia
Cubist says antibiotic regimen will get a fast-track review as a treatment for 3 infections
Yahoo/AP
Wed, 05/8/13 - 10:48 am
fast track
FDA
Cubist Pharmaceuticals
hospital-acquired bacterial pneumonia
antibiotics